We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $419M invested in Adverum Biotechnologies in 2014 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
1.68%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
58
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$99.3M
2
DM
Deerfield Management
New York
+$60.9M
3
VM
VHCP Management
New York
+$41.1M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$30.7M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$114M +$99.3M +333,729 New
DM
2
Deerfield Management
New York
$70M +$60.9M +204,768 New
VM
3
VHCP Management
New York
$42.8M +$41.1M +138,274 New
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$34.2M +$30.7M +103,275 New
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$25M +$21.8M +73,121 New
RG
6
Redmile Group
California
$21.5M +$20.8M +69,946 New
JP Morgan Chase
7
JP Morgan Chase
New York
$15.3M +$13.3M +44,775 New
FCM
8
Frontier Capital Management
Massachusetts
$13.5M +$11.8M +39,595 New
TCP
9
Tourbillon Capital Partners
New York
$10.3M +$8.93M +30,000 New
CI
10
Cowen Inc
New York
$8.5M +$7.4M +24,867 New
Goldman Sachs
11
Goldman Sachs
New York
$6.68M +$5.81M +19,528 New
BFA
12
BlackRock Fund Advisors
California
$5.81M +$5.06M +16,995 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$5.19M +$4.52M +15,178 New
QF
14
QVT Financial
New York
$4.1M +$3.57M +12,000 New
Franklin Resources
15
Franklin Resources
California
$3.98M +$3.46M +11,630 New
Lord, Abbett & Co
16
Lord, Abbett & Co
New Jersey
$3.49M +$3.04M +10,208 New
Jennison Associates
17
Jennison Associates
New York
$3.42M +$2.98M +10,000 New
CAM
18
Cormorant Asset Management
Massachusetts
$2.22M +$1.93M +6,500 New
BIT
19
BlackRock Institutional Trust
California
$1.96M +$1.71M +5,731 New
State Street
20
State Street
Massachusetts
$1.94M +$1.69M +5,680 New
BA
21
BlackRock Advisors
Delaware
$1.83M +$1.59M +5,355 New
PRCM
22
Pine River Capital Management
Minnesota
$1.77M +$1.54M +5,179 New
GTC
23
Ghost Tree Capital
New York
$1.71M +$1.49M +5,000 New
Citadel Advisors
24
Citadel Advisors
Florida
$1.58M +$1.38M +4,632 New
Primecap Management
25
Primecap Management
California
$1.57M +$1.37M +4,590 New
1
2 3

ADVM Hedge Fund Activity: Q3 2014 in Review

58 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2014, worth a combined $419M.

Buyers outnumbered sellers: 58 funds opened new ADVM positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $99.3M.

  • 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $419M of Adverum Biotechnologies stock for Q3 2014.
  • 58 funds opened new Adverum Biotechnologies positions in Q3 2014 and 0 closed out, a net change of +58 holders.
  • The largest Adverum Biotechnologies buyer in Q3 2014 was Fidelity Investments, an estimated $99.3M added.

Based on aggregated 13F filings for Q3 2014.